BNP Paribas Financial Markets
VIVO

BNP Paribas Financial Markets’s Meridian Bioscience Inc VIVO Stock Holding History

BNP Paribas Financial Markets’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,883
Closed -$229K – 4144
2022
Q4 		$229K Sell
6,883
-7,970
-54% -$257K ﹤0.01% 2951
2022
Q3 		$468K Sell
14,853
-4,609
-24% -$149K ﹤0.01% 3030
2022
Q2 		$592K Sell
19,462
-35,062
-64% -$948K ﹤0.01% 2566
2022
Q1 		$1.42M Buy
54,524
+6,764
+14% +$161K ﹤0.01% 2078
2021
Q4 		$974K Buy
47,760
+2,753
+6% +$52.8K ﹤0.01% 2611
2021
Q3 		$866K Buy
45,007
+24,635
+121% +$491K ﹤0.01% 2465
2021
Q2 		$452K Buy
20,372
+6,365
+45% +$135K ﹤0.01% 2575
2021
Q1 		$368K Buy
14,007
+991
+8% +$23.6K ﹤0.01% 2748
2020
Q4 		$243K Buy
13,016
+2,070
+19% +$38.7K ﹤0.01% 2786
2020
Q3 		$186K Buy
10,946
+7,071
+182% +$137K ﹤0.01% 2792
2020
Q2 		$90.2K Sell
3,875
-13,939
-78% -$202K ﹤0.01% 2809
2020
Q1 		$150K Buy
17,814
+7,396
+71% +$62.3K ﹤0.01% 3006
2019
Q4 		$102K Buy
10,418
+2,820
+37% +$26.5K ﹤0.01% 3290
2019
Q3 		$72.1K Sell
7,598
-1,076
-12% -$11.3K ﹤0.01% 3296
2019
Q2 		$103K Sell
8,674
-1,014
-10% -$12.2K ﹤0.01% 3017
2019
Q1 		$171K Buy
9,688
+7,258
+299% +$121K ﹤0.01% 2795
2018
Q4 		$42.2K Sell
2,430
-89
-4% -$1.52K ﹤0.01% 2797
2018
Q3 		$37.5K Sell
2,519
-4,444
-64% -$68.9K ﹤0.01% 3166
2018
Q2 		$111K Sell
6,963
-69,095
-91% -$1.03M ﹤0.01% 2740
2018
Q1 		$1.08M Sell
76,058
-3,862
-5% -$57.2K ﹤0.01% 1680
2017
Q4 		$1.12M Buy
79,920
+57,797
+261% +$846K ﹤0.01% 1902
2017
Q3 		$316K Buy
22,123
+7,221
+48% +$103K ﹤0.01% 2219
2017
Q2 		$235K Buy
14,902
+6,269
+73% +$90.3K ﹤0.01% 2355
2017
Q1 		$119K Buy
8,633
+960
+13% +$13.4K ﹤0.01% 2431
2016
Q4 		$136K Buy
7,673
+286
+4% +$5.02K ﹤0.01% 2403
2016
Q3 		$142K Sell
7,387
-6,686
-48% -$131K ﹤0.01% 1922
2016
Q2 		$274K Buy
14,073
+7,077
+101% +$139K ﹤0.01% 1782
2016
Q1 		$144K Sell
6,996
-2,348
-25% -$46.3K ﹤0.01% 1663
2015
Q4 		$192K Buy
9,344
+634
+7% +$12.2K ﹤0.01% 1962
2015
Q3 		$149K Buy
8,710
+5,064
+139% +$92.6K ﹤0.01% 2148
2015
Q2 		$68K Buy
3,646
+2,652
+267% +$49.2K ﹤0.01% 2306
2015
Q1 		$19K Buy
+994
New +$18.4K ﹤0.01% 2392
2014
Q4 		– Sell
-2,445
Closed -$43.3K – 3409
2014
Q3 		$43.3K Buy
2,445
+2,292
+1,498% +$45K ﹤0.01% 2687
2014
Q2 		$3.16K Buy
+153
New +$3.14K ﹤0.01% 2844
2014
Q1 		– Sell
-537
Closed -$14.2K – 3905
2013
Q4 		$14.2K Sell
537
-10,615
-95% -$261K ﹤0.01% 2412
2013
Q3 		$264K Sell
11,152
-3,308
-23% -$77.3K ﹤0.01% 2036
2013
Q2 		$311K Buy
+14,460
New +$312K ﹤0.01% 1958

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

BNP Paribas Financial Markets's VIVO Position: Q1 2023 in Review

BNP Paribas Financial Markets sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 6,883 shares — an estimated $229K sold.

BNP Paribas Financial Markets first reported a position in VIVO in Q2 2013 and held it in 37 quarters. The position peaked at $1.42M in Q1 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • BNP Paribas Financial Markets reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 6,883 Meridian Bioscience Inc shares in Q1 2023, an estimated $229K.
  • BNP Paribas Financial Markets first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 37 quarters.
  • BNP Paribas Financial Markets's Meridian Bioscience Inc position peaked at $1.42M in Q1 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2023, filed 12 May 2023.